Galectin Therapeutics (GALT)
(Delayed Data from NSDQ)
$2.67 USD
+0.01 (0.38%)
Updated Oct 18, 2024 03:59 PM ET
After-Market: $2.68 +0.01 (0.37%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Earnings News For GALT
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update
-
UPDATE ? Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2023 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2023 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2022 and Provides Business Update